Dorzolamide and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dorzolamide and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dorzolamide ophthalmic
Brand name: Trusopt
Synonyms: Dorzolamide ophthalmic
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dorzolamide-Insulin degludec
- Dorzolamide-Insulin Degludec (U-100) Prefilled Pens
- Dorzolamide-Insulin Degludec (U-100) Vials
- Dorzolamide-Insulin Degludec (U-200) Prefilled Pens
- Dorzolamide-Insulin degludec and liraglutide
- Dorzolamide-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dorzolamide and Timolol
- Insulin aspart, recombinant Subcutaneous-Dorzolamide and Timolol Eye Drops
- Insulin aspart, recombinant Subcutaneous-Dorzolamide and timolol ophthalmic
- Insulin aspart, recombinant Subcutaneous-Dorzolamide and Timolol Ophthalmic Solution
- Insulin aspart, recombinant Subcutaneous-Dorzolamide and Timolol Preservative-Free Eye Drops
- Insulin aspart, recombinant Subcutaneous-Dorzolamide Hydrochloride